27 results
Therapeutic Indications for the Anticonvulsant Agents

#Anticonvulsant #Antiseizure #Medications #Pharmacology #Table #Neurology #Epilepsy #Management
Anticonvulsant Agents ... #Medications #Pharmacology ... #Table #Neurology
Key Characteristics of Old and New Potassium-Binding Agents

- Dr. Edgar V. Lerma https://twitter.com/edgarvlermamd

#Potassium #Binding #KBinders #Kayexelate
Potassium-Binding Agents ... Kayexelate #Comparison #Table ... #Pharmacology # ... #HyperKalemia #Nephrology ... #Agents
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... Infections in HIV-AIDS Preventing ... Penicilliosis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Managing Microsporidiosis in HIV-AIDS
Preventing Chronic Microsporidiosis:
 • Because chronic microsporidiosis occurs
IDSA Recommendations ... for Preventing ... CD4 count >100 cells ... Microsporidiosis #IDSA ... infections #HIVAIDS #pharmacology
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Summary of Diuretic Agents ... #Medications #Pharmacology ... #summary #table ... #nephrology
Vancomycin Associated Acute Kidney Injury

 • Drug induced acute kidney injury is generally defined as a
other nephrotoxic agents ... Treatment includes prevention ... to alternative agents ... Vancomycin #AKI #pharmacology ... diagnosis #management #nephrology
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
IDSA Recommendations ... for Preventing ... CD4 count >100 cells ... Cryptosporidiosis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... CD4 count <100 cells ... #Encephalitis #IDSA ... #pharmacology
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Potential Treatment Agents ... infection Episode #Pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology